Sponsored Content

A New Framework for Identifying Nitrosamine Risks and Efficiently Derisking Products

A clear standard for identifying APIs susceptible to NDSRI formation has remained elusive – until now.

Company Logo

Released By Adare Pharma Solutions

A clear standard for identifying APIs susceptible to NDSRI formation has remained elusive – until now. Adare’s team of nitrosamine experts have developed a straightforward framework that simplifies the identification of at-risk APIs.

Fill out the form to download the article >>>

Download Sponsored Content Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters